ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

Letter to the Editor

March 21, 2003

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011